title: An HLA lost mutation may lead to leukemic relapse of recipient type six years after bone marrow transplantation.
authors.forename: H
authors.initials: H
authors.lastname: Grosse-Wilde
authors.forename: I
authors.initials: I
authors.lastname: Doxiadis
authors.forename: U
authors.initials: U
authors.lastname: Vögeler
authors.forename: H K
authors.initials: HK
authors.lastname: Mahmoud
authors.forename: U W
authors.initials: UW
authors.lastname: Schäfer
authors.forename: D W
authors.initials: DW
authors.lastname: Beelen
authors.forename: H L
authors.initials: HL
authors.lastname: Ploegh
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D006680:HLA Antigens / Q000235:genetics*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000628:therapy*; D009154:Mutation; D010375:Pedigree; D013997:Time Factors
chemical_list: D006680:HLA Antigens